Unusual Clinical Manifestations of Leishmania (L.) infantum chagasi in an HIV-coinfected Patient and the Relevance of ITS1-PCR-RFLP: A Case Report
Patients coinfected with Leishmania/HIV can develop atypical forms of visceral leishmaniasis (VL), making it indispensable to identify the etiological agent. We are presenting a postmortemspecie definition by ITS1-PCR-RFLP in a larynx tissue of a patient presented coinfectionLeishmania/HIV. This patient was from a leishmaniasis endemic region in São Paulo(SP), Brazil, and was diagnosed clinically with mucocutaneous leishmaniasis. Before a rK39immunochromatographic test positive, a tiny stored paraffin-embedded larynx tissue wasobtained post-mortem and submitted to 3 conventional PCR assays: kDNA (K20/K22 and
RV1/RV2), and ITS1 (LITSR/ L5.8S). The last one was followed by RFLP (HaeIII) andanalyzed by 4% Metaphor agarose gel electrophoresis. Leishmania genus and Leishmania(Leishmania) subgenus were defined by kDNA-PCR, with K20/K22 (120 bp) and RV1/RV2(145 bp), respectively. ITS1-PCR-RFLP identified L. (L.) infantum chagasi species visualizedby the restriction patterns of 180, 70 and 50 bp. This case draws attention to the necessityfor a clear identification of the etiological agent causing infection, especially in endemicregions of cutaneous and visceral leishmaniasis, and particularly in patients with comorbidities
who often present atypical forms of the disease. L. (L.) infantum chagasi, which is usuallyresponsible for VL, had changed its clinical spectrum for mucocutaneous. Unequivocalidentification was carried out by ITS-PCR-RFLP, therefore confirming rK39 result. Thesetechniques, which complemented each other, have a convenient cost-benefit ratio thatmakes them suitable to be applied in developing countries.
Pourahmad M, Hooshmand F, Rahiminejad M. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS). Int J Dermatol. 2009;48(1):59-61.
Ara M, Maillo C, Peón G, Clavel A, Cuesta J, Grasa MP, et al. Visceral leishmaniasis with cutaneous lesions in a patient infected with human immunodeficiency virus. Br J Dermatol. 1998;139(1):114-7.
Schönian G, Kuhls K, Mauricio IL. Molecular approaches for a better understanding of the epidemiology and population genetics of Leishmania. Parasitology. 2011;138(4):405-25.
Ritmeijer K, Melaku Y, Mueller M, Kipngetich S, O'keeffe C, Davidson RN. Evaluation of a new recombinant K39 rapid diagnostic test for Sudanese visceral leishmaniasis. Am J Trop Med Hyg. 2006;74(1):76-80.
Secretaria de Estado da Saúde de São Paulo, Centro de Vigilância Epidemiológica , Centro de Vigilância Sanitária, Instituto Adolfo Lutz. [Data on hospital infection, external causes of death, and visceral leishmaniose in the state of São Paulo, Brazil]. Rev Saude Publica. 2004;38(1):141-4.
Brasil, Ministério da Saúde, Sistema de Agravos de Notificação Sinan-NET. Leishmaniose tegumentar - casos confirmados notificados no sistema de informação de agravos de notificação - Brasil Online: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinannet/cnv/ltasp.def 2016 [
Brasil, Ministério da Saúde,Centro de Vigilância Epidemiológica. Manual de vigilância e controle da leishmaniose visceral Brasilia Online http://bvsms.saude.gov.br/bvs/publicacoes/manual_vigilancia_controle_leishmaniose_visceral_1edicao.pdf 2014
Voller A, Bidwell DE, Bartlett A. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ. 1976;53(1):55-65.
de Godoy NS, Andrino ML, de Souza RM, Gakiya E, Amato VS, Lindoso J, et al. Could kDNA-PCR in Peripheral Blood Replace the Examination of Bone Marrow for the Diagnosis of Visceral Leishmaniasis? J Parasitol Res. 2016;2016:1084353.
Gomes AH, Ferreira IM, Lima ML, Cunha EA, Garcia AS, Araújo MF, et al. PCR identification of Leishmania in diagnosis and control of canine Leishmaniasis. Vet Parasitol. 2007;144(3-4):234-41.
Schönian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HD, Presber W, et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis. 2003;47(1):349-58.
Trindade MA, Silva LL, Braz LM, Amato VS, Naafs B, Sotto MN. Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review. BMC Infect Dis. 2015;15:543.
Burkardt HJ. Standardization and quality control of PCR analyses. Clin Chem Lab Med. 2000;38(2):87-91.
Nigro L, Montineri A, La Rosa R, Zuccarello M, Iacobello C, Vinci C, et al. Visceral leishmaniasis and HIV co-infection: a rare case of pulmonary and oral localization. Infez Med. 2003;11(2):93-6.
|Issue||Vol 13 No 4 (2018)|
|Visceral leishmaniasis HIV coinfeccion Mucocutaneous manifestation Leishmania (L.) infantum chagasi RFLP|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|